Respiratory Trials·org

Topic

Nephrology in critical care

Timing of renal replacement therapy and fluid choice.

What the evidence shows

Wait before starting dialysis. Accelerated initiation did not reduce mortality and left more patients dialysis-dependent at 90 days (STARRT-AKI); many in the standard arm never needed dialysis at all. There is a limit to that patience — postponing further than a delayed strategy caused harm without benefit (AKIKI 2). Once started, dialysing less often was associated with faster recovery of kidney function (LIBERATE-D).

Modality does not matter provided the delivery is careful: intermittent haemodialysis matched continuous therapy for survival in multi-organ failure (Hemodiafe).

Balanced fluid is not better than saline. The physiological case against chloride-rich fluid was strong, and two large trials found the clinical difference negligible (PLUS, BaSICS).

Choice of crystalloid

Trial Year Therapy Effect Finding
PLUS 2022 Balanced multielectrolyte solution Balanced fluid was no better than saline in critically ill adults
BaSICS 2021 Balanced solution Balanced solution did not improve survival over saline in over ten thousand patients

When to start dialysis

Trial Year Therapy Effect Finding
AKIKI 2 2021 More-delayed initiation Waiting even longer than a delayed strategy caused harm without benefit
STARRT-AKI 2020 Accelerated initiation Starting dialysis early did not save lives and left more patients dialysis-dependent

Continuous or intermittent dialysis

Trial Year Therapy Effect Finding
Hemodiafe 2006 Intermittent haemodialysis Intermittent haemodialysis matched continuous therapy when delivered carefully

Dialysis intensity and recovery

Trial Year Therapy Effect Finding
LIBERATE-D 2026 Conservative dialysis strategy Dialysing less often led to faster recovery of kidney function and less hypotension

Key references

Guidelines, standards and reviews for this topic.